South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:South Texas Accelerated Research Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10926
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
South Texas Accelerated Research Therapeutics (START) accelerates the development of novel anticancer agents that improves personalized and clinical care for cancer patients. The company offers preclinical and clinical research services which include pharmacokinetics, in vivo and in vitro services; regulatory affairs support; drug investigation studies; preclinical models and assays to accelerate oncology drug development; and others. It also conducts phase I medical oncology programs using innovative information technology infrastructure for rapid clinical trials, as well as patient tumor model program to accelerate drug discovery and development for the treatment of cancer. The company has operations with offices in the China and Spain. START is headquartered in San Antonio, Texas.

South Texas Accelerated Research Therapeutics – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
South Texas Accelerated Research Therapeutics, Medical Devices Deals, 2012 to YTD 2018 9
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
South Texas Accelerated Research Therapeutics and Sarah Cannon Research Institute Enter into Partership 11
SA1KCGP, WuXi NextCODE and START Enter into Partnership 12
Denovo Sciences Enters into Research Agreement with South Texas Accelerated Research Therapeutics 13
South Texas Accelerated Research Therapeutics – Key Competitors 14
South Texas Accelerated Research Therapeutics – Key Employees 15
South Texas Accelerated Research Therapeutics – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Key Facts 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
South Texas Accelerated Research Therapeutics, Deals By Therapy Area, 2012 to YTD 2018 8
South Texas Accelerated Research Therapeutics, Medical Devices Deals, 2012 to YTD 2018 9
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
South Texas Accelerated Research Therapeutics and Sarah Cannon Research Institute Enter into Partership 11
SA1KCGP, WuXi NextCODE and START Enter into Partnership 12
Denovo Sciences Enters into Research Agreement with South Texas Accelerated Research Therapeutics 13
South Texas Accelerated Research Therapeutics, Key Competitors 14
South Texas Accelerated Research Therapeutics, Key Employees 15
South Texas Accelerated Research Therapeutics, Other Locations 16

List of Figures
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
South Texas Accelerated Research Therapeutics, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • J.E. Dunn Construction Group Inc:企業の戦略的SWOT分析
    J.E. Dunn Construction Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Linklaters Llp:企業の戦略・SWOT・財務分析
    Linklaters Llp - Strategy, SWOT and Corporate Finance Report Summary Linklaters Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Aslan Pharmaceuticals Pte Ltd:企業のM&A・事業提携・投資動向
    Aslan Pharmaceuticals Pte Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aslan Pharmaceuticals Pte Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Barton Malow Co:企業の戦略的SWOT分析
    Barton Malow Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • NuStar Energy LP (NS):石油・ガス:M&Aディール及び事業提携情報
    Summary NuStar Energy LP (NuStar Energy) is a midstream oil and gas company. It carries out the transportation, terminalling, storage and marketing of petroleum products, and anhydrous ammonia. The company owns and operates pipelines, terminal and storage facilities that store and distribute crude o …
  • Nammo AS:企業の戦略・SWOT・財務情報
    Nammo AS - Strategy, SWOT and Corporate Finance Report Summary Nammo AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Feilo Sylvania Europe Ltd:企業の戦略的SWOT分析
    Feilo Sylvania Europe Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ABC arbitrage SA (ABCA):企業の財務・戦略的SWOT分析
    ABC arbitrage SA (ABCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • SKF AB:企業の戦略・SWOT・財務分析
    SKF AB - Strategy, SWOT and Corporate Finance Report Summary SKF AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Hurricane Energy plc (HUR):企業の財務・戦略的SWOT分析
    Summary Hurricane Energy Plc (Hurricane) is an oil and gas exploration and development company that discovers and develops oil from fractured basement reservoirs. The company provides exploration properties such as lancaster basement prospect, whirlwind basement discovery, lincoln basement prospect, …
  • Schneider Electric SE (SU)-石油・ガス分野:企業M&A・提携分析
    Summary Schneider Electric SE (Schneider Electric), formerly Schneider Electric SA, is an energy management and automation company that develops related technologies and solutions for electricity distribution. Its product line comprises automation and control products, building management and securi …
  • Monsanto Company:企業の戦略・SWOT・財務情報
    Monsanto Company - Strategy, SWOT and Corporate Finance Report Summary Monsanto Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • New Zealand Post Ltd:企業の戦略的SWOT分析
    New Zealand Post Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Staples, Inc.:企業の戦略・SWOT・財務分析
    Staples, Inc. - Strategy, SWOT and Corporate Finance Report Summary Staples, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • AT&T Inc:企業のM&A・事業提携・投資動向
    AT&T Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AT&T Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Furukawa Electric Co Ltd (FUWAY):企業の財務・戦略的SWOT分析
    Furukawa Electric Co Ltd (FUWAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Trina Solar Ltd:企業の戦略的SWOT分析
    Trina Solar Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • AAR Corp:企業の戦略・SWOT・財務情報
    AAR Corp - Strategy, SWOT and Corporate Finance Report Summary AAR Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Largan Precision Co Ltd (3008):企業の財務・戦略的SWOT分析
    Largan Precision Co Ltd (3008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • BBB Technologies Inc:企業の製品パイプライン分析2018
    Summary BBB Technologies Inc (BBB Tech) is a development stage medical technology company that develops medical devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. The company discovers and develops single-drop and mobile integrated diagnostic tool …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆